20.11.2018 • NewsAshlandDede WillamsIneos

Ashland to Sell Composites to Ineos

Ashland to Sell Composites to Ineos (c) Ineos
Ashland to Sell Composites to Ineos (c) Ineos

Ashland Global Holdings is selling the Ashland composite resins business to Swiss-based olefins and polyolefins giant Ineos for an undisclosed sum. The deal includes activities with annual turnover of $1.1 billion as well as a 100,000 t/y butane diol facility at Marl, Germany, which produces key intermediates for high performance polyesters and polyurethanes.

The transaction is due to close in the first half of next year, subject to regulatory approvals. The activities to be transferred employ 1,300 people at 20 sites in Europe, North and South America, Asia and Middle East.

Bill Wulfsohn, CEO of Dublin, Ohio-based Ashland is divesting the activities to pare down debt toward the goal of establishing itself “a premier specialty chemicals company with a more streamlined and focused product portfolio, improved margins and reduced earnings volatility.”

Ashland touts its composites business line as a global leader in unsaturated polyester resins, vinyl ester resins and gel coats. Along with a wide range of gelcoats, it also produces corrosion-resistant fiberglass-reinforced plastic (FRP), a high performance material used in challenging environments.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.